The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.

JOURNAL OF SPINAL CORD MEDICINE, published by Taylor & Francis Ltd, serves as a pivotal platform in the field of neurology, particularly focusing on spinal cord research and clinical practices. With an emphasis on advancing knowledge and clinical understanding, this journal has been committed to disseminating high-quality research since its inception in 1995 and continues its mission into 2024. Holding a Q3 ranking in the clinical neurology category, it is recognized among its peers, attracting a diverse readership of researchers, healthcare professionals, and students dedicated to the complexities of spinal cord medicine. Although it does not currently offer open access, it remains an authoritative source of innovative studies, systematic reviews, and case reports that contribute to enhancing patient care and clinical outcomes in the field. With an ISSN of 1079-0268 and an E-ISSN of 2045-7723, the journal stands out as an essential resource for those engaged in spinal cord medicine research and practice.

American Journal of Physical Medicine & Rehabilitation, published by Lippincott Williams & Wilkins, is a leading journal in the field of rehabilitation, dedicated to advancing knowledge in physical medicine and rehabilitation practices. With an established history from 1988 to 2024, this journal serves as a vital resource for clinicians, researchers, and students interested in the multifaceted aspects of rehabilitation science. It holds a commendable Q2 ranking in the Physical Therapy and Sports Therapy fields and a prestigious Q1 position in Rehabilitation, reflecting its impact and relevance in the academic community. The journal's Scopus rankings further highlight its significance, placing it among the top percentile for both rehabilitation medicine and physical therapy. Although it does not currently offer open access options, its accessibility through institutional subscriptions ensures widespread reach. By publishing high-quality research, clinical studies, and reviews, the American Journal of Physical Medicine & Rehabilitation plays a critical role in shaping contemporary rehabilitation practices and improving patient outcomes.

Gynecologic Oncology Reports is a pivotal interdisciplinary journal published by Elsevier Science Inc. that has been dedicated to advancing the understanding of women's health since its inception in 2014. This Open Access journal, available to a global audience, facilitates the dissemination of high-quality research in the fields of gynecology and oncology, allowing for the free exchange of knowledge and fostering collaboration among researchers, clinicians, and students. With an impact factor reflective of its commitment to clinical relevance, Gynecologic Oncology Reports holds a Q3 ranking in both obstetrics and gynecology as well as oncology categories, contributing to its visibility and the prestige of published work. Situated in the Netherlands and operating within an open-access framework, it ensures that critical findings and advancements reach a broad readership. The journal serves as a vital resource for those aiming to stay at the forefront of gynecologic oncology, promoting improved patient outcomes through cutting-edge research. As it converges towards its 10th anniversary in 2024, Gynecologic Oncology Reports continues to be an essential platform for scholarly communication in this important field.

CLINICAL OBSTETRICS AND GYNECOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, stands as a pivotal journal in the field of obstetrics and gynecology, boasting a rich history since its inception in 1958. With its ISSN 0009-9201 and E-ISSN 1532-5520, the journal serves as a critical repository of contemporary research and clinical advancements, providing invaluable insights to healthcare professionals and researchers. As a prominent Q2 ranked journal in the Obstetrics and Gynecology category, it is recognized for its impactful contributions to medical practice and education, holding a respectable Scopus rank of #103 out of 209, placing it in the 50th percentile. While not an open-access journal, it ensures wide dissemination of knowledge through institutional subscriptions, enhancing the accessibility of its peer-reviewed content. The scope of the journal encompasses a diverse range of topics vital to the ongoing evolution of women's health, making it an essential resource for those dedicated to fostering clinical excellence and advancing research in obstetrics and gynecology.

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

The International Journal of Reproductive Biomedicine, an esteemed publication by SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, serves as a pivotal platform in the fields of obstetrics and gynecology as well as reproductive medicine. Established in 2011 and transitioning to an open access model in 2015, this journal facilitates the dissemination of innovative research and critical findings to a global audience, particularly focusing on advancements in reproductive health and biomedicine. With an impact factor reflective of its commitment to high-quality scientific inquiry, the journal has achieved a notable ranking of Q3 in both its categories for 2023, contributing to its growing influence within the academic community. Researchers and professionals benefit from its broad scope, which encompasses a range of topics essential to reproductive health, thus fostering a rich exchange of knowledge. The journal's accessibility allows students and professionals alike to engage with the latest findings and contribute to ongoing discussions within this vital field of study.

Menopause Review-Przeglad Menopauzalny is a distinguished peer-reviewed journal published by TERMEDIA PUBLISHING HOUSE LTD, focusing on crucial aspects of women's health during the menopausal transition and beyond. With an Open Access format since its inception in 2002, this journal ensures wide dissemination of research findings, catering to an international audience. Recognized for its impact within the academic community, it holds a notable Q3 rating in Endocrinology, Diabetes and Metabolism and a Q2 rating in Obstetrics and Gynecology as of 2023, reflecting its relevance and authority in these fields. Residing in Poland, the journal aims to explore a diverse range of topics that contribute to the understanding of menopause, offering researchers, health professionals, and students valuable insights and updates. Positioned within a competitive landscape, with Scopus rankings that underscore its commitment to quality, Menopause Review remains an essential resource for advancing knowledge and improving clinical practices related to menopausal health.

GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.

Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.